Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Accured Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Kura Oncology (KURA) Shares Issued (2023 - 2026)

Kura Oncology has reported Shares Issued over the past 4 years, most recently at $69000.0 for Q1 2026.

Quarterly Shares Issued fell 51.75% to $69000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Mar 2026, down 72.24% year-over-year, with the annual reading at $1.8 million for FY2025, 79.16% down from the prior year.
Shares Issued was $69000.0 for Q1 2026 at Kura Oncology, down from $1.1 million in the prior quarter.
Over five years, Shares Issued peaked at $3.0 million in Q2 2024 and troughed at $69000.0 in Q1 2026.
The 4-year median for Shares Issued is $749000.0 (2023), against an average of $1.1 million.
Year-over-year, Shares Issued skyrocketed 2521.43% in 2024 and then tumbled 94.4% in 2025.
A 4-year view of Shares Issued shows it stood at $691000.0 in 2023, then rose by 16.79% to $807000.0 in 2024, then soared by 40.64% to $1.1 million in 2025, then tumbled by 93.92% to $69000.0 in 2026.
Per Business Quant, the three most recent readings for KURA's Shares Issued are $69000.0 (Q1 2026), $1.1 million (Q4 2025), and $515000.0 (Q2 2025).